AUGUSTA UNIVERSITY
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1828-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.augusta.edu
Vitamin K to Slow Progression of Dyslipidemia and Diabetes Risk (Vita-K 'n' Kids Study II)
Not Applicable
- Conditions
- Interventions
- First Posted Date
- 2016-11-09
- Last Posted Date
- 2019-11-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 30
- Registration Number
- NCT02959762
- Locations
- 🇺🇸
Medical College of Georgia; Augusta University, Augusta, Georgia, United States
Ketamine as an Adjuvant Therapy for Acute Vaso Occlusive Crisis in Pediatric Patients With Sickle Cell Disease
- First Posted Date
- 2016-06-15
- Last Posted Date
- 2016-06-15
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 20
- Registration Number
- NCT02801292
Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary Disease
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-05-17
- Last Posted Date
- 2021-02-23
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 15
- Registration Number
- NCT02774226
- Locations
- 🇺🇸
Georgia Prevention Institute, Augusta, Georgia, United States
The Role of Endothelin-1 in Sickle Cell Disease
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2020-04-02
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 26
- Registration Number
- NCT02712346
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Mechanisms for Vascular Dysfunction and Exercise Tolerance in CF
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 13
- Registration Number
- NCT02690064
- Locations
- 🇺🇸
Georgia Prevention Institute, Augusta, Georgia, United States
Study of FOND Versus FOND+O for the Prevention of CINV in Hematology Patients Receiving Highly Emetogenic Chemotherapy Regimens
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-12-21
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 108
- Registration Number
- NCT02635984
- Locations
- 🇺🇸
Augusta University Medical Center, Augusta, Georgia, United States
Low Pulse Amplitude Focal ECT (LAP Study)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-10-22
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 11
- Registration Number
- NCT02583490
- Locations
- 🇺🇸
Medical Colleage of Georgia, Augusta University, Evans, Georgia, United States
Neuromodulation Therapy for Fecal Incontinence
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2019-02-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 44
- Registration Number
- NCT02556151
- Locations
- 🇬🇧
University of Manchester, Manchester, United Kingdom
🇺🇸Augusta University, Augusta, Georgia, United States
Effects of an Immunosuppressant Mycophenolate Mofetil or MMF on the Urinary Sodium Excretion Response to Mental Stress
Phase 1
- Conditions
- Interventions
- First Posted Date
- 2015-05-04
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 50
- Registration Number
- NCT02432339
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
Effectiveness of Prazosin on the Urinary Sodium Excretion Response to Mental Stress
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2015-05-01
- Last Posted Date
- 2019-06-20
- Lead Sponsor
- Augusta University
- Target Recruit Count
- 50
- Registration Number
- NCT02431936
- Locations
- 🇺🇸
Augusta University, Augusta, Georgia, United States
© Copyright 2024. All Rights Reserved by MedPath